Total Payments
$5,358
2024 Payments
$1,314
Companies
20
Transactions
305
Medicare Patients
5,759
Medicare Billing
$350,053
Payment Breakdown by Category
Food & Beverage$5,278 (98.5%)
Education$79.99 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,278 | 304 | 98.5% |
| Education | $79.99 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,332 | 120 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $980.22 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $485.82 | 20 | $0 (2024) |
| Lilly USA, LLC | $412.22 | 23 | $0 (2024) |
| UCB, Inc. | $352.51 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $350.44 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $305.97 | 15 | $0 (2024) |
| Amgen Inc. | $293.89 | 14 | $0 (2024) |
| GENZYME CORPORATION | $255.75 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $141.87 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,314 | 71 | ABBVIE INC. ($312.29) |
| 2023 | $1,119 | 52 | Regeneron Healthcare Solutions, Inc. ($261.52) |
| 2022 | $973.87 | 61 | ABBVIE INC. ($248.44) |
| 2021 | $939.43 | 57 | Novartis Pharmaceuticals Corporation ($232.12) |
| 2020 | $295.88 | 20 | AbbVie Inc. ($212.41) |
| 2019 | $505.96 | 36 | Novartis Pharmaceuticals Corporation ($194.95) |
| 2018 | $99.51 | 6 | Sun Pharmaceutical Industries Inc. ($25.73) |
| 2017 | $110.81 | 2 | MERZ NORTH AMERICA, INC. ($60.81) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $83.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Immunology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Oncology | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,688 | 2,935 | $298,750 | $101,313 |
| 2022 | 15 | 1,561 | 2,506 | $260,824 | $91,103 |
| 2021 | 15 | 1,248 | 1,940 | $210,330 | $79,134 |
| 2020 | 12 | 1,262 | 1,966 | $216,676 | $78,503 |
Total Patients
5,759
Total Services
9,347
Medicare Billing
$350,053
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 38 | 39 | $8,778 | $3,788 | 43.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 29 | 47 | $9,338 | $3,724 | 39.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 44 | 59 | $5,723 | $2,353 | 41.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 19 | $6,669 | $2,248 | 33.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 13 | 14 | $1,122 | $458.47 | 40.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 14 | $42.00 | $11.93 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 216 | 249 | $33,402 | $14,034 | 42.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 229 | 266 | $33,966 | $10,580 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 99 | $19,293 | $9,287 | 48.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 106 | 112 | $19,257 | $8,077 | 41.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 105 | 105 | $20,475 | $6,863 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $14,256 | $5,438 | 38.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 48 | 62 | $12,383 | $5,340 | 43.1% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 51 | 54 | $12,291 | $5,177 | 42.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 85 | 96 | $7,862 | $4,093 | 52.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 159 | 718 | $18,668 | $3,418 | 18.3% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 21 | 23 | $8,073 | $2,856 | 35.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 44 | 44 | $6,023 | $2,090 | 34.7% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 19 | 31 | $3,007 | $1,308 | 43.5% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 16 | 17 | $1,326 | $556.96 | 42.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 15 | 16 | $48.00 | $15.15 | 31.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 191 | 244 | $32,208 | $12,815 | 39.8% |
| 17000 | Destruction of skin growth | Office | 2020 | 224 | 256 | $30,266 | $10,346 | 34.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 143 | 143 | $27,885 | $9,995 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 127 | $24,638 | $9,346 | 37.9% |
About Dr. Jessica Sempler, M.D
Dr. Jessica Sempler, M.D is a Dermatology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1457619033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Sempler, M.D has received a total of $5,358 in payments from pharmaceutical and medical device companies, with $1,314 received in 2024. These payments were reported across 305 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,278).
As a Medicare-enrolled provider, Sempler has provided services to 5,759 Medicare beneficiaries, totaling 9,347 services with total Medicare billing of $350,053. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Missoula, MT
- Active Since 05/02/2012
- Last Updated 06/28/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1457619033
Products in Payments
- SKYRIZI (Biological) $770.45
- DUPIXENT (Biological) $694.50
- COSENTYX (Biological) $533.34
- COSENTYX (Drug) $442.38
- TALTZ (Drug) $412.22
- Sotyktu (Drug) $305.97
- TREMFYA (Drug) $283.69
- Cimzia (Drug) $255.32
- RINVOQ (Biological) $238.08
- Otezla (Drug) $229.01
- HUMIRA (Biological) $173.39
- OPZELURA (Drug) $136.88
- Humira (Biological) $107.55
- ILUMYA (Biological) $102.73
- Bimzelx (Biological) $97.19
- EUCRISA (Drug) $78.87
- Enbrel (Biological) $64.88
- REMICADE (Biological) $50.19
- VTAMA (Drug) $39.01
- Skyrizi (Biological) $32.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Missoula
Shannon Foster, M.d, M.D
Dermatology — Payments: $11,217
Dermatology $11,217
Troy Davis, Pa-C, PA-C
Dermatology — Payments: $5,646
Dermatology $5,646
Andrew Tegeder, Md, MD
Dermatology — Payments: $3,539
Dermatology $3,539
Erika Hagstrom, Md, MD
Dermatology — Payments: $1,643
Dermatology $1,643
Jacob Inda, Md, MD
Dermatology — Payments: $1,488
Dermatology $1,488
Allyson Yelich, D.o, D.O
Dermatology — Payments: $843.25
Dermatology $843.25